CTI BioPharma (NASDAQ:CTIC) +55% announces FDA accelerated approval of VONJ (pacritinib) for the treatment of adult patients with myelofibrosis and thrombocytopenia.
American Rebel (NASDAQ:AREB) +24%.
3D Systems (NYSE:DDD) +14% on Q4 results.
Lilium N.V. (NASDAQ:LILM) +8%.
Editas Medicine (NASDAQ:EDIT) +11% rides on patent win for Broad Institute in CRISPR gene editing.
Target (NYSE:TGT) +11% on Q4 results.
51job (NASDAQ:JOBS) +10% after report buyout group nearing $61/share takeout.
Atea Pharmaceuticals (NASDAQ:AVIR) +10% on Q4 results.
LivePerson (NASDAQ:LPSN) +11% after activist Starboard takes stake.
Marathon Digital Holdings (NASDAQ:MARA) +9%.
Redbox Entertainment (NASDAQ:RDBX) +9%.
Riot Blockchain (NASDAQ:RIOT) +7%.
Legend Biotech (NASDAQ:LEGN) +8% J&J, Legend Biotech's Carvykti for multiple myeloma gets US FDA approval.
Hut 8 Mining (NASDAQ:HUT) +7%.
Cabaletta Bio (NASDAQ:CABA) +7% U.S. Food and Drug Administration grants Cabaletta bio fast track designation for MuSK-CAART.
Bitfarms (NASDAQ:BITF) +7% mines 67% more new BTC in February from prior year.
Equinor (NYSE:EQNR) +7% BP planning to sell Rosneft stake to ... Rosneft.
Sphere 3D (NASDAQ:ANY) +7%.
Chico's FAS (NYSE:CHS) +6% on Q4 results.
Bakkt Holdings (NYSE:BKKT) +6%.
Puhui Wealth Investment (NASDAQ:PHCF) +6%.
CleanSpark (NASDAQ:CLSK) +6%.
Denison Mines (NYSE:DNN) +6%.
BitNile Holdings (NYSE:NILE) +6% reports estimated annualized run rate of 360.99 Bitcoin in February, higher M/M.
HIVE Blockchain (NASDAQ:HIVE) +6%.
Disclaimer : The above empty space does not represent the position of this platform. If the content of the article is not logical or has irregularities, please submit feedback and we will delete or correct it, thank you!
COPYRIGHT © 2021-2023 HZD.COM & WWW.HZD.AI ALL RIGHTS RESERVED
